EWML
FATE icon

Eiger Wealth Management, LLC’s Fate Therapeutics FATE Stock Holding History

Eiger Wealth Management, LLC’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.7K Hold
10,000
– – 0.51% 17
2026
Q2 		$27K Hold
10,000
– – 0.85% 12
2026
Q1 		$12K Hold
10,000
– – 0.39% 13
2025
Q4 		$9.8K Buy
+10,000
New +$12K 0.26% 16

Other funds holding FATE

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
PM
Parametrica Management Wanchai, Hong Kong $142M AUM 113.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Eiger Wealth Management, LLC's FATE Position: Q3 2026 in Review

Eiger Wealth Management, LLC held its Fate Therapeutics (FATE) position steady in Q3 2026 at 10,000 shares worth $23.7K. The position accounts for 0.51% of the portfolio, ranked #17.

Eiger Wealth Management, LLC first reported a position in FATE in Q4 2025 and has held it in 4 quarters since. The position peaked at $27K in Q2 2026. 28 funds tracked by Wall St. Rank hold FATE as of Q3 2026.

  • Eiger Wealth Management, LLC held 10,000 shares of Fate Therapeutics worth $23.7K as of Q3 2026.
  • Eiger Wealth Management, LLC left its Fate Therapeutics share count unchanged in Q3 2026.
  • Fate Therapeutics made up 0.51% of Eiger Wealth Management, LLC's portfolio in Q3 2026, its #17 holding.
  • Eiger Wealth Management, LLC first reported a position in Fate Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Eiger Wealth Management, LLC's Fate Therapeutics position peaked at $27K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.

Based on Eiger Wealth Management, LLC's 13F filing for Q3 2026, filed 3 Nov 2026.